Clinical Trial Update: Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing combined transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) versus RFA monotherapy for unilobar hepatocel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Shi-Ming Lin | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN